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ABSTRACT Structural complexity is an inherent feature of the human telomeric sequence, and it presents a major challenge for
developing ligands of pharmaceutical interest. Recent studies have pointed out that the induction of a quadruplex or change of
a quadruplex conformation on binding may be the most powerful method to exert the desired biological effect. In this study, we
demonstrate a quadruplex ligand that binds selectively to different forms of the human telomeric G-quadruplex structure and
regulates its conformational switch. The results show that not only can oxazine750 selectively induce parallel quadruplex forma-
tion from a random coil telomeric oligonucleotide in the absence of added cations, it also can easily surpass the energy barrier
between two structures and change the G-quadruplex conformation in Naþ or Kþ solution. The combination of its unique prop-
erties, including the size and shape of the G-quadruplex and the small molecule, is proposed as the predominant force for regu-
lating the special structural formation and transitions. These results may stimulate the design of new quadruplex binders that
would be capable of discriminating different G-quadruplex structures as well as controlling biological phenomena, functional
molecules, and nanomaterials.doi: 10.1016/j.bpj.2009.07.025INTRODUCTION
Chromosomes in human cells are capped at both ends with
noncoding tandem (TTAGGG)n tracts called telomeres.
DNA replication produces a blunt-ended leading strand
telomere and a lagging strand telomere carrying a single-
stranded G-rich overhang of 100–200 nucleotide (nt) at its
end (1,2). The 30G-rich overhang can fold to form a unique
secondary DNA structure that has three stacked guanine
tetrads, which is termed an intramolecular G-quadruplex
(3–8). Since the substrate of telomerase is the 30-single-
stranded overhang of telomeric DNA, the formation and
function of these G-quadruplexes are currently of great
interest because of their roles in important biological pro-
cesses, such as aging and cancer, and their potential as ther-
apeutic targets for cancer (9–12). Furthermore, ligands that
selectively bind to G-quadruplex motifs have become the
focus of attention in recent years because they may interfere
with telomere structures, telomere elongation/replication,
and proliferation of cancer cells. To date, a diverse array of
G-quadruplex-stabilizing compounds have been identified
(13–24), and convincing reports on the efficiency of quadru-
plex interacting molecules as therapeutically active reagents
are beginning to appear in the literature. Some of these
compounds have shown encouraging biological effects
in vitro that go beyond telomerase inhibition, including telo-
meric disruption, formation of anaphase bridges, apoptosis,
and in vivo activity in mouse xenograft models (25–27).
However, there is no general code that explains the ligand-
quadruplex binding, and a sequence/conformation-depen-
dent interaction may also be important.
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0006-3495/09/10/2014/10 $2.00G-rich oligonucleotides can be very polymorphic, and
the adopted structures are dependent on several factors,
including the base sequence, strand concentration, loop
connectivities, and cations present. In the case of a human
telomere DNA repeat, there are 208 possible structures
when the eight possible quartet orientation combinations are
considered with the 26 possible folds (28,29). Experimen-
tally, only four actual structures have been determined. The
first of these was observed by NMR spectroscopy in Naþ solu-
tion, which revealed an intramolecular antiparallel basket-
type G-quadruplex structure with alternating directions of
the G3 runs (3). The basket-type G-quadruplex has one diag-
onal and two lateral or edgewise loops. In 2002, a very
different G-quadruplex structure of the same sequence was
observed in a Kþ-containing crystal (4). In this propeller-
type structure, all four strands are parallel and the connecting
TTA loops are double chain reversal loops. More recently, an
NMR-derived hybrid, or mixed conformation with three
parallel and one antiparallel orientation of the guanine
columns, was reported (6,7) (Scheme 1). These different types
highlight the remarkable diversity found in the single-chain
topology.
Although recent biological investigations confirmed the
efficiency of quadruplex ligands as antiproliferative agents,
they also showed that the mechanisms underlying the drug
action can be drastically more complex (30,31), as the bio-
logical and biochemical consequences of binding of ligands
to G-quadruplex structures found in telomeres and promoter
regions of certain important oncogenes go beyond mere
stabilization of these structures (16). It has also been pointed
out that it is not necessary for a compound to target an exist-
ing cellular quadruplex to have biological activity;
the induction of a quadruplex or change of a quadruplex
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to exert the desired biological effect (32). Furthermore,
switching between antiparallel and parallel G-quadruplexes
of guanine-rich telomere DNAs plays a vital role in chromo-
some association (33). It has been observed that molecular
crowding with neutral polymers induced transition from
the antiparallel to the parallel G-quadruplex, or from the
intramolecular G-quadruplex to a long, multistranded
G-wire structure, and the formation of parallel G-quadruplex
(34–36). Some divalent metal ions have also been reported to
affect the stability of the antiparallel G-quadruplex and
induce its structural transition to the parallel form (37,38).
Although many elegant studies on G-quadruplex binders
have appeared, it would be interesting to determine whether
G-quadruplex ligands stabilize the hybrid-type, parallel/anti-
parallel, or other type of G-quadruplex folding. To date, only
slight progress has been made in discriminating specific
quadruplexes, and only a few small molecules have been
reported to influence the structural transition of G-quadru-
plexes (16,18–20,22,23,39). Telomestatin, a natural product
isolated from Streptomyces amulatus 3533-SV4, is the most
potent inhibitor of telomerase, and under certain conditions
it can convert the preformed mixed-type hybrid human
telomeric G-quadruplex to the antiparallel basket form
(16). Under the same conditions, the synthetic, expanded
porphyrin compound Se2SAP can convert the preformed
basket-type to a hybrid G-quadruplex (16). Recently, a dieth-
ylene triamine modified anthracene compound was reported
to induce the folding of G-quadruplex from single-stranded
DNA under salt-deficient conditions through a threading
and stacking mode (19). Oxazine dyes are an important
group of chromophoric compounds that are used as biolog-
ical stains (e.g., to monitor Alzheimer’s disease), fluores-
cence standards, and laser dyes (40–42). Recently, we found
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SCHEME 1 Schematic representation of oxazine750 bound selectively
to different forms of human telomeric G-quadruplex DNA, structures of
oxazine750, and the three types of intramolecular human telomeric
G-quadruplex.that a member of this family, oxazine170, a small crescent-
shaped cationic molecule with four fused aromatic rings,
could selectively induce the formation of a hybrid triplex
structure, poly rA:(poly dT)2, under solution conditions in
which the triplex would not otherwise form (43). In this
study, we demonstrate for the first time (to our knowledge)
that its analogue, oxazine750 (Scheme 1), shows preferential
binding to the parallel form of human telomeric G-quadru-
plex. Oxazine750 is unique in that not only can it selectively
induce parallel quadruplex formation from a random coil
telomeric oligonucleotide in the absence of added cations
such as Kþ, and Naþ, it can also regulate the transition of
the preformed antiparallel or mixed-type hybrid G-quadru-
plex to the parallel form.
MATERIALS AND METHODS
See the Supporting Material.
RESULTS AND DISCUSSION
Oxazine750 facilitates the formation of parallel
human telomeric G-quadruplex
G-quadruplex can exist in parallel, antiparallel, and mixed-
type parallel/antiparallel structures depending on the different
cations present (3–8). Although the relation between circular
dichroism (CD) spectra and topology is not very clear, it has
been suggested that, for the most part, the various topologies
of quadruplex DNA can be correlated with specific CD signa-
tures (19,44,45). An antiparallel structure is characterized
by a negative peak near 260 nm and a positive peak near
295 nm, whereas a parallel structure displays a negative
peak near 240 nm followed by a positive peak near 264 nm
(16,19,36,37), and a mixed-hybrid structure has two positive
maxima at 295 and 268 nm (16). In the absence of ligand, the
CD spectrum of human telomeric d[AG3(T2AG3)3] oligonu-
cleotide was found to have a negative band centered at
238 nm, a major positive band at 257 nm, and a minor nega-
tive band at 280 nm, consistent with an unstructured single
strand. However, upon addition of excess oxazine750 to the
solution at room temperature, a dramatic change in the CD
spectrum was observed. The bands at 238, 257, and 280 nm
disappeared, and negative and positive CD bands at 241 and
263 nm appeared (Fig. 1 A). The resultant CD spectrum is
characteristic of a parallel quadruplex and indicates that oxa-
zine750 binds to DNA and causes substantial changes in the
conformation of the DNA. Furthermore, in the presence of
oxazine750, an induced CD signal for the ligand was observed
between 520 and 710 nm (Fig. 1 B, square). This induced
signal is additional evidence for the interaction between the
DNA and ligand, since its appearance in the CD spectra is
indicative of the change in the chirality of the proximal chem-
ical environment of oxazine750. For comparison, another two
parallel G-quadruplex structures that were formed in NaþBiophysical Journal 97(7) 2014–2023
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FIGURE 1 (A) CD spectra of d[AG3(T2AG3)3] with
oxazine750, d[AG3(A3G3)3] with Na
þ and oxazine750,
and d[TG4T]4 with Na
þ in 10 mM Tris-HCl, pH 7.4. (B)
Induced CD signal for d[AG3(T2AG3)3] with oxazine750
is observed between 580 and 710 nm in 10 mM Tris-
HCl, pH 7.4. DNA concentrations were 2 mM/strand for
all of the sequences.solution by the d[TG4T]4 oligonucleotide (46) and the mutant
d[AG3(A3G3)3] oligonucleotide (47,48) are also included in
Fig. 1 A, further supporting the notion that d[AG3(T2AG3)3]
adopts a parallel-stranded topology in solution, as in the Kþ
crystalline state (4). The CD spectrum of the ligand-induced
human telomeric G-quadruplex d[AG3(T2AG3)3] under
salt-deficient conditions best matches the signature patterns
of the parallel G-quadruplex. In addition, once the parallel
structure is formed, this conformation is not changed upon
the addition of even 100 mM Naþ (see Fig. S3 in the Support-
ing Material). Since factors such as the base sequence, strand
concentration and/or orientation, and loop connectivities may
all influence the ligand binding, we also examined the effect of
oxazine750 on other distinct G-quadruplex DNAs: the two-
repeat Oxytricha nova telomeric sequence d[G4T4G4]2, the
24 nt monomeric Oxytricha nova telomeric sequence
d[(T4G4)4], and the tetramolecular d[TG4T]4 oligonucleotide.
It has been shown that d[TG4T]4 forms a parallel G-quadru-
plex (46), and the d[G4T4G4]2 and d[(T4G4)4] sequences
form an antiparallel G-quadruplex in Naþ (23,38). However,
oxazine750 does not induce either the parallel or antiparallel
G-quadruplex for these sequences under salt-deficient condi-
tions (Fig. S1 C). We further investigated the effect of the
flanking sequence d[(T2AG3)4] and the mutant sequence
d[AG3(A3G3)3] on formation of the G-quadruplex. For the
flanking sequence that has two extra Ts in the 50 end compared
to the 22 nt human telomeric oligonucleotide, the same CD
bands appeared (data not shown), indicating that an identical
parallel G-quadruplex structure is formed. Our data show
that the 50-end capping does not influence the induction of
the parallel human telomeric G-quadruplex by oxazine750.Biophysical Journal 97(7) 2014–2023Of interest, for the mutant sequence in which the thymine resi-
dues in the loop region were mutated to adenines, a character-
istic major positive band at 263 nm and a minor negative band
at 243 nm appeared upon the addition of oxazine750 (Fig. 1).
This phenomenon was previously reported for the parallel
structure of d[AG3(A3G3)3] (47,48), which suggests that
oxazine750 converts single-stranded mutant telomeric DNA
into a parallel G-quadruplex in the absence of added salt. In
addition, the intensity of the positive band at 263 nm in the
presence of oxazine750 is almost twice as great as that in
100 mM Naþ, indicating that oxazine750 alone has a much
more strong stabilizing effect than 100 mM Naþ for the mutant
sequence. These results demonstrate that oxazine750 is
capable of discriminating between quadruplexes, and the
specific selectivity of the human telomeric G-quadruplex is
related not only to the G-quadruplex topology, but also to
composition of the sequence and loop.
To gain further insight into the facilitating and stabilizing
effects on the parallel G-quadruplex by oxazine750, we
carried out thermal denaturation studies (Fig. 2). G-quadru-
plexes have different stabilities in different concentrations
of cations, as reflected by their melting temperature (Tm)
(49). Fig. 2 A shows that the telomeric sequence exhibited
hypochromicity in the presence of oxazine750 without the
addition of salt, whereas no transition was seen in the absence
of ligand. The Tm value (45.5
C) is close to that obtained in
10 mM Naþ solution (43.1C), which indicates that oxa-
zine750 induced the formation of a stable G-quadruplex
and mimicked the effect of at least 10 mM Naþ solution in
terms of thermal stability. Furthermore, oxazine750 showed
a more dramatic stabilizing effect for the mutant sequence:20 40 60 80
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FIGURE 2 (A) CD melting curves of 2 mM d[AG3
(T2AG3)3] with 10 mM Na
þ, with 16 mM oxazine750
in the absence of added salt and with 10 m Naþ and
16 mM oxazine750. (B) CD melting curves of 5 mM
d[AG3(A3G3)3] with 100 mM Na
þ and with 40 mM oxa-
zine750 in the absence of added salt . Absorbance changes
were collected at 263 nm for the parallel G-quadruplex and
295 nm for the antiparallel G-quadruplex, respectively.
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with a Tm of <20
C in 100 mM Naþ buffer (Fig. 2 B) (47).
In contrast, the oxazine750-induced parallel G-quadruplex
had a Tm of 36.2
C. The stabilization induced by oxazine750
far exceeded that by 100 mM Naþ with aDTm of 18C, which
is fully consistent with the large CD intensity change shown in
Fig. 1 A.
Oxazine750 affects and regulates the type
of G-quadruplex conformation found in solution
To date, several group 1 and 2 metal cations and NH4
þ ions
have been identified as stabilizing the G-quadruplex; of these,
Kþ and Naþ are the most abundant intracellular cations with
clear physiological relevance. Therefore, in this section we
focus our attention on how oxazine750 might affect the equi-
librium between different G-quadruplex structures found in
Naþ and Kþ solutions. We first investigated the structure
and stability of d[AG3(T2AG3)3] with oxazine750 in the
presence of Naþ. As shown in Fig. 2 A, d[AG3(T2AG3)3]
forms a stable antiparallel structure with a Tm of 43.1
C as
described earlier in the presence of 10 mM Naþ (see Fig. S1
for the CD spectra in 10 mM Naþ). Upon the addition of
oxazine750, the CD spectra dramatically changes again,
with a disappearance of the maxima at 295 and 243 nm, and
the minima at 264 nm that corresponds to antiparallel G-quad-
ruplex structures, and the emergence of parallel conformation
characteristics with the distinctive maxima and minima
patterns of 263 and 243 nm (shown in Fig. 3). These spectra
closely resemble those of the same sequence with oxazine750
in the absence of salt. The results suggest that the structural
transition from the antiparallel to the parallel G-quadruplex
occurred continuously and cooperatively with the ligand titra-
tion (Fig. S2 A). In addition, the conformational switch of
d[AG3(T2AG3)3] oligonucleotide by oxazine750 in 10 mM
Naþ was verified by thermal denaturation analysis. As shown
in Fig. 2 A, the Tm value (44.6
C) is almost the same as that
in the presence of ligand alone, which further demonstrates
that oxazine750 has the ability to convert either the random
structure or the preformed antiparallel G-quadruplex that is
present in the 10 mM Naþ condition exclusively into the
parallel G-quadruplex conformation. These results are consis-
tent with the CD spectra obtained at different temperaturesunder the same conditions (Fig. S2 B). The structural
transition between the antiparallel and parallel G-quartet of
the 24 nt monomeric Oxytricha nova telomeric sequence
d[(T4G4)4] has been shown in a phase diagram, in which
225 mM Naþ or 65 mM Kþ was required for the transition
from an antiparallel to a parallel structure (33). Recently,
Miyoshi et al. (37,38) showed that a parallel G-quartet of
d[G4T4G4]2 was induced from an antiparallel structure by
1 mM Caþ in the presence of 7 mM Naþ. However, in the
study presented here, only a few micromole ligands could
induce the parallel human telomeric G-quadruplex structure
in the presence of 10 mM Naþ, indicating that a specific
ligand-G-quartet interaction is essential for the structure tran-
sition, and that the specific ligand-G-quartet interaction may
be stronger than the Naþ coordination and replace the need
for monovalent cations to facilitate the formation and regula-
tion of G-quadruplex structures under certain conditions.
Since it has been shown that G-quadruplexes formed by
d[AG3(T2AG3)3] are more stable at elevated monovalent
cations (48), we explored the effect of oxazine750 on
d[AG3(T2AG3)3] in 100 mM Na
þ. The samples were heat-de-
natured and cooled to ensure that the structures were formed
under the intended environment before CD recordings were
obtained. In the presence of eight equivalents of oxazine750,
the CD spectrum showed a dramatic change (Fig. S3). The
coexistence of the characteristics of the antiparallel and
parallel conformers suggests that the structure formed here
is a quadruplex that contains mixed parallel/antiparallel
components, or that it is a mixture of G-quadruplex structures
that have parallel and antiparallel characteristics. To gain
further insight into the ligand-induced structural changes,
we carried out ultraviolet (UV) melting under the same condi-
tions. The melting curve of d[AG3(T2AG3)3] in the presence
of 100 mM Naþ was found to be monophasic (Fig. 3 B), indi-
cating the melting of one type of the oligonucleotide, and that
the Tm value (58.3
C) was much higher than that observed in
10 mM Naþ solution (43.1C). Of interest, upon the addition
of four equivalents of oxazine750, an apparently broad and
biphasic melting profile was obtained (Fig. 3 B), indicating
the existence of two species, each of which showed distinct
quadruplex melting transitions.
A low melting transition with a Tm value of ~40
C is fol-
lowed by a higher temperature transition with a Tm value of-2
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FIGURE 3 (A) CD spectra of 2 mM d[AG3(T2AG3)3]
with Naþ and oxazine750. (B) Normalized UV melting
curves of 2 mM d[AG3(T2AG3)3] with 100 mM Na
þ (black
line), with 100 mM Naþ and 8 mM oxazine750 (open
square), and with 100 mM Naþ and 20 mM oxazine750
(circle). Absorbance changes were collected at 295 nm.Biophysical Journal 97(7) 2014–2023
2018 Chen et al.~60C. When the amount of ligand was further increased by
10 equivalents, the Tm values of the two transitions were
almost unaffected. However, a significantly increased hypo-
chromicity of the low melting profile was observed (Fig. 3 B).
Keeping in mind that the ligand-induced parallel G-quadru-
plex structure has a melting transition at ~43C in the absence
of added cations or in 10 mM Naþ solution, it can be
concluded that the lower temperature transition corresponds
to the melting of the parallel quadruplex species, whereas
the higher temperature transition is the melting of the antipar-
allel quadruplex species. The hypochromicity of the melting
curve indicates that a more parallel G-quadruplex conforma-
tion was formed when the amount of ligand was increased.
These results demonstrate that the solution contained mixed
parallel/antiparallel components in the presence of oxa-
zine750 at 100 mM Naþ, and further confirm that the
small-molecule oxazine750 bound selectively to the parallel
G-quadruplex and regulated its structural transition. The
structural transition of d[AG3(T2AG3)3] oligonucleotide
induced by oxazine750 in the presence of different concentra-
tions of Naþ suggests that the effect of the ligand on the tran-
sition is competitive with Naþ in facilitating the formation of
the G-quadruplex.
AG3 forms a mixed conformation in K
þ solution, and Kþ is
more potent than Naþ in stabilizing a G-quadruplex structured
as a result of the relative free energies, hydration state, and
ionic radius for optimal sphere coordination (19). The unique
characteristics of oxazine750 in salt-deficient conditions and
in Naþ solution raise the possibility that it could also affect the
equilibrium between different G-quadruplex structures in Kþ
solution. Indeed, we found that the addition of the ligand
induced the development of a new conformation. In 6 mM
Kþ solution, the CD spectrum of d[AG3(T2AG3)3] showed
a distinctive shoulder located near 270 nm on the strong posi-
tive band at 289 nm, and a small negative peak near 235 nm
(Fig. 4 A), similar to previous findings for human telomeric
DNA in Kþ solution (16,23). Upon the addition of oxa-
zine750, pronounced and dramatic changes were observed
(Fig. 4 A). Thus, it seems that the major species induced by
oxazine750 in the presence of Kþ is a mixture of species or,
alternatively, is a mixed-type hybrid G-quadruplex. Since
sodium has a low binding affinity for d[AG3(T2AG3)3]
G-quadruplex, and the ligand had a different effect on theBiophysical Journal 97(7) 2014–2023quadruplex in Naþ and Kþ solution, we analyzed the thermal
stability of the quadruplex in the presence and absence of
oxazine750 in Kþ solution. The results in Fig. 4 B show
that the quadruplex had a Tm of 51.0
C in 6 mM Kþ, which
is more stable than that in 10 mM Naþ (43.1C). In contrast,
the quadruplex had an unusual stability with a Tm of nearly
77C in the presence of oxazine750, which far exceeded
that by oxazine750 in Naþ solution with a Tm stability of
44.6C. In addition, we also investigated the effect of
oxazine750 in 20 mM Kþ. As shown in Fig. S4, the CD spec-
trum is similar to that with oxazine750 in 6 mM Kþ. The CD
melting showed a higher stability, with a Tm of 59
C in the
absence of ligand, and again an unusual stability was
observed, with a Tm of nearly 79
C in the presence of oxa-
zine750, which is close to that in 6 mM Kþ (Fig. 4 B).
Compared to the competitive effect of oxazine750 in Naþ
solution, the unusual behavior in Kþ solution indicates that
oxazine750 may have a synergetic effect with Kþ on the
G-quadruplex transition. Molecular crowding has been
reported to induce the transition from antiparallel to parallel
quadruplex in Oxytricha nova telomeric DNA, and from intra-
molecular G-quadruplex to long multistranded G-wire in
Tetrahymena (T2G4)3T2G2 DNA (34,35). Under molecular
crowding conditions created by polyethylene glycol (PEG),
d[AG3(T2AG3)3] was shown to form a G-quadruplex free of
added cation, and adopt a parallel-stranded conformation in
Kþ solution (36). To further understand the interaction
between oxazine750 with d[AG3(T2AG3)3] in solution, we
carried out studies using PEG 200 as the crowding agent
without adding a cation. The CD spectrum in 40% (w/v)
PEG is similar to that previously reported and features
a shoulder near 270 nm and a positive band at 289 nm, which
are characteristic of a mixture of both parallel and antiparallel
G-quadruplexes (Fig. 4 A, triangle). After the addition of
eight equivalents of oxazine750, we observed a strong posi-
tive band at 262 nm and negative signal at 242 nm (Fig. 4 A,
open triangle), respectively. A previous report showed that
PEG induced a conformational conversion with an increase
in PEG concentration in Kþ solution, and a mixed-type hybrid
topology and a parallel-stranded topology were formed
when PEG reached 30% and 40% (w/v), respectively (36).
Our CD results match the key signatures of the parallel
d[AG3(T2AG3)3] quadruplex DNA formed in 150 mM K
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FIGURE 4 (A) CD spectra of 2 mM d[AG3(T2AG3)3]
with Kþ and/or PEG and oxazine750: with no salt added
(square), with 6 mM Kþ (open square), with 6 mM Kþ
and oxazine750 (circle), with 40% PEG 200 (triangle),
and with 40% PEG 200 and oxazine750 (open triangle).
(B) CD melting curves of 2 mM d[AG3(T2AG3)3] with
6 mM Kþ and with 6 mM Kþ and 16 mM oxazine750.
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FIGURE 5 Plot of fluorescence intensity at 370 nm of 2-Ap individually
labeled d[AG3(T2AG3)3] versus concentration of oxazine750. DNA concen-40% PEG solution, suggesting that d[AG3(T2AG3)3] adopted
a parallel-stranded conformation in the presence of oxa-
zine750 under molecular crowding condition, and that oxa-
zine750 has the same ability as a >150 mM Kþ solution in
terms of regulating the quadruplex conformation. Although
oxazine750 can not totally convert the d[AG3(T2AG3)3]
DNA into a parallel conformation in Kþ solution as it does
in 40% PEG, it is worthwhile to note that the CD profile
was almost identical to the mixed-type hybrid structure
formed in 30% (w/v) PEG (36). This result indicates that
the ligand has effects equivalent to those of 30% PEG on
the equilibrium between different G-quadruplexes. Collec-
tively, the data shown here support the hypothesis that oxa-
zine750 prefers the parallel conformation and has a synergetic
effect with Kþ in stabilizing the G-quadruplex and regulating
its structural transition.
Mode of binding
Although the detailed mechanism of how oxazine750 folds
and regulates d[AG3(T2AG3)3] conformation changes
remains to be resolved, knowing the binding mode could
help us understand the special selectivity of the ligand. Ami-
nopurine (Ap) is a fluorescent adenine isomer that is able to
form a Watson-Crick basepair with thymine, and has been
widely used to probe local conformational changes in
DNA as well as to verify the mode of ligand binding to
G-quadruplex and i-motif DNA (23,50,51). In our study,
the quadruplex was strategically substituted with 2-Ap at
specific adenine residues (Ap7, Ap13, and Ap19; Fig. 5).
The fluorescent intensities of the Aps are very similar to
each other after added oxazine750 in the absence of added
salt, which agrees with the similar local environment for
the adenine residues in the random structure (Fig. S5). In
contrast, the fluorescent intensity in Naþ solution followed
the order Ap7 > Ap19 > Ap13, as previously reported for
the same structure (23,51). The large difference in fluores-
cence emission between the Aps reflects the heterogeneity
of the TTA looping conformations in the Naþ solution. In
the early structure (3), A13 is packed within a diagonal
loop at one end of the quadruplex, and A7 and A19 are in
separate lateral loops at the opposite end. The titration of
oxazine750 into a solution of the Ap-modified d[AG3
(T2AG3)3] oligonucleotide in 100 mM Na
þ shows a decrease
in Ap fluorescence following the order A7 z A19 > A13
(Fig. 5 A). This indicates that oxazine750 may bind to the
end of the G-quartet by external stacking and contacts with
the two lateral loops, a binding mode that has been
tration was fixed at 1.0 mM (single strand conc.) and titrated by oxazine750
in different buffer at 15C. Fluorescence emission spectra were recorded
from 320 nm to 500 nm with an excitation wavelength at 305 nm. Squares:
Ap7 in loop 1; circles: Ap13 in loop 2; triangles: Ap19 in loop 3. (A)
d[AG3(T2AG3)3] with 100 mM Na
þ. (B) d[AG3(T2AG3)3] with 10 mM
Naþ. (C) d[AG3(T2AG3)3] with 100 mM K
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2020 Chen et al.demonstrated in previous reports (23). In contrast, the fluo-
rescence intensity changes of the Aps became very similar
to each other in the absence of added cation or in 10 mM
Naþ (Fig. 5 B). Note that for the parallel conformation in
Kþ solution, the crystal structure shows that residues A7,
A13, and A19 are all in equivalent loop environments,
with each intercalated between thymine residues (4). This
result reflects the structural conversion induced by oxa-
zine750, in agreement with the structural symmetry for the
three external TTA loops. In addition, since the parallel-
stranded human telomeric quadruplex has been also
observed in Kþ solution under molecular crowding condi-
tions created by PEG (36), we also analyzed the effect of ox-
azine750 on the Aps of the parallel quadruplex. The results
in Fig. 5 C show that addition of oxazine750 affected resi-
dues to almost identical extents, further supporting the notion
that oxazine750 bonds to the end of the parallel G-quartet by
external stacking.
The gel electrophoresis technique is sensitive to structural
conformations and has been extensively used to study
G-quadruplex folding and the mode of ligand binding
(23,51,52). S1 nuclease is widely used as an analytical
tool for determining nucleic-acid structure. It binds to an
exposed single strand, such as in a hairpin loop, and attacks
the O-30-P bond. The binding mode of oxazine750 is further
supported by S1 endonuclease cleavage. Fig. S6 shows the
cleavage pattern of 50-fluorescein-labeled oligomer exposed
S1 nuclease for 10 min at 25C after incubation with
different concentrations of oxazine750. All three bands
appear to be due to cleavage within TAA loops, consistent
with previous studies (23,51,52). The first S1 cleavage
occurred in loop 1 near the 50 end with the shortest length,
the second cleavage occurred in loop 2 with intermediate
length, and the third cleavage occurred in loop 3 near the
30 end with the longest length. For the antiparallel G-quad-
ruplex formed in 100 mM Naþ solution, the lateral loop 1
was the most labile to S1 nuclease in the absence of added
ligand (Fig. S6 A). Upon addition of increasing concentra-
tions of oxazine750, a decreased cleavage at loop 1 and
an increased cleavage at loop 3 were observed, whereas
the cleavage at loop 2 was hardly influenced. This cleavage
pattern is in accordance with our 2-Ap fluorescence studies
and further supports the notion that oxazine750 binds to the
end of the G-quartet by external stacking and contacts with
the two lateral loops. Note that at higher concentrations of
oxazine750 (Fig. S6 A, line 5), a modestly increased
cleavage for loop 2 was observed, which is different from
that found at lower ligand concentrations, indicating an
increased accessibility of this loop to S1 nuclease. Keep
in mind that in our early melting and CD studies, oxa-
zine750 binding at a relative higher concentration resulted
in partial parallel G-quadruplex formation at 100 mM
Naþ. We speculated that this increased cleavage could be
due to the partially formed parallel G-quadruplex structure
in which loop 2 was in a propeller-like configuration. OfBiophysical Journal 97(7) 2014–2023interest, a different cleavage pattern was found in the
absence of added salt: cleavages in loops 2 and 3 were
apparently increased upon the addition of increasing
concentrations of oxazine750, and at the same time
a dramatically decreased S1 cleavage was observed at
loop 1 (Fig. S6 B). This different cleavage pattern demon-
strates that the environments of the three propeller-like
loops may be significantly affected by the ligand binding,
leading to an increased accessibility of loops 2 and 3 to
S1 nuclease. Stacking of the A-T basepairs in loop 1 was
especially increased by oxazine750, because this loop was
the most labile to S1 nuclease in the absence of oxazine750
but was substantially protected from cleavage after oxa-
zine750 binding. Furthermore, as shown in the melting
and CD studies (Figs. 1 and 2), oxazine750 binding resulted
in a stable parallel G-quadruplex formation. This result
shows a dramatic increasing intensity of the full-length
d[AG3(T2AG3)3] oligonucleotide, demonstrating that the
parallel structure was stabilized and greatly protected from
cleavage upon the addition of oxazine750. Overall, these
results are fully consistent with oxazine750 converting the
randomly structured oligomer exclusively into the parallel
G-quadruplex and having an end-stacking type of binding
propensity.
Although the detailed mechanism of the structural transi-
tion of d[AG3(T2AG3)3] regulated by oxazine750 remains to
be determined in further studies, we speculated that the
combination of the unique structural character of the parallel
G-quadruplex and oxazine750 molecule may be the key
factor in quadruplex specificity and discrimination. As
mentioned in the Introduction, previous studies with small
molecules have shown different effects on the G-quadruplex
structural transition and/or the formation of the intramolecu-
lar human telomeric sequence (16,18,20,23). Recently, a
naphthyridine dimer was shown to act as a molecular glue
in the assembly of two telomeric sequences by binding
strongly to G-G mismatches in the hypothetical duplex of
a telomeric dimmer (39). On the other hand, different
G-quadruplex conformations may also contribute to the
specificity or selectivity of a ligand binding. For example, a
dominant feature of parallel DNA quadruplexes is that they
present the large surface area of their terminal G-quartet to
the environment (4). In cocrystals of a telomeric oligonucle-
otide and the anticancer drug daunomycin, three daunomy-
cins were found to stack onto the 50 end of the quadruplex
(46). Overall, these results are supportive of our speculation:
the specific oxazine-quadruplex interaction is probably the
predominant force for the structural induction and conver-
sion. In support of our reasoning, we found that relatively
small changes in the structure of oxazine750 significantly
altered binding and selectivity. Nile blue is an analogue
of oxazine750. Both of these two benzo[a]phenoxazine
dyes have amino or substituted amino groups in the 5- and
9-positions, whereas oxazine750 has two extra rings at the
8-, 9-, and 10-positions (Fig. S7). Under the exact same
G-Quadruplex Conformational Switch 2021conditions used for oxazine750, we found that Nile blue
neither induced the G-quadruplex formation nor influenced
the structural conformation. UV or CD melting showed
that it interacted with the antiparallel-type G-quadruplex.
In addition, the titration of Nile blue into a solution of the
Ap-modified d[AG3(T2AG3)3] oligonucleotide in 100 mM
Naþ showed a decrease in Ap fluorescence following the
order A7 z A19 > A13 (Fig. S8), indicating that, like
many other G-quadruplex binders, it may also bind to the
end of the G-quartet by external stacking and contacts with
the two lateral loops (23). Results from the gel electropho-
resis studies (Fig. S9) are also fully consistent with the pref-
erence of antiparallel conformation for Nile blue. It should be
noted that a dominant feature of parallel DNA quadruplexes
is that they present the large surface area of their terminal
G-quartet to the environment (4,47). Thus, the more-
extended surface of the oxazine molecule could fit well
and pack tightly onto the end of the quadruplex stack, with
the positive side chain forming H-bonding interactions
and/or van der Waals contacts with the quadruplex groove.
Furthermore, UV-visible (UV-vis) titrations were carried
out in the absence of salt to determine the stoichiometry
for oxazine750 binding to the human telomeric G-quadru-
plex structure. A sample of the d[AG3(T2AG3)3] was titrated
by oxazine750 with the sum total concentration of ligand
and oligonucleotide held constant at 5 mM. After each addi-
tion of oxazine750, the reaction was allowed to equilibrate
for 20 min and the spectrum was collected. Fig. S10 A shows
that the d[AG3(T2AG3)3] G-quadruplex bound four mole-
cules of oxazine750. Our observation is not without prece-
dent, although to our knowledge no structural rationalization
has yet been presented for these kinds of high-binding stoi-
chiometries. Studies carried out by De Cian et al. (21) using
the same human telomeric sequence described the quadru-
plex-binding properties of new members of the bisquinoli-
nium family: In the presence of Naþ, the ligand bound to
the antiparallel G-quadruplex with a binding mode of stack-
ing of the ligand onto the two external G-quartet, whereas in
Kþ solution under certain condition, a ligand-induced struc-
tural change was observed along with a 4:1 binding stoichi-
ometry. A binding isotherm for the interaction of oxazine750
with G-quadruplex was also obtained by UV-vis measure-
ments (Fig. S10 B). An association constant of 3.7(51.0) 
106 M1 was determined from the titration data. In our case,
the ligands could interact with the larger G-quartet involving
end stacking and external binding, or through end stacking
and ligand aggregation. However, given the larger surface
area of the parallel terminal G-quartet, which can simulta-
neously accommodate three-daunomycin molecules (46),
this molecule could also have a binding propensity for stack-
ing two oxazine750 molecules onto the G-quartet. In simi-
larity to the bisquinolinium family (21), the dimension of
the dimeric oxazine750 molecules (Fig. S11) is closely
related to that of the G-quartet, and thus the selectivity and
discrimination could originate from this accurate geometriccomplementarity. Furthermore, it well explains the structural
conversion from the antiparallel to the parallel form, since
the presence of diagonal and lateral loops in the antiparallel
telomeric quadruplex could weaken the end stacking of
oxazine750 molecules. More evidence is necessary to verify
the proposed binding mode, and further investigation is
under way in our laboratory.
CONCLUSIONS
Structural complexity is an inherent feature of the human
telomeric sequence, and it presents a major challenge for
developing ligands of pharmaceutical interest. To date,
only slight progress has been made in achieving specificity
between G-quadruplex conformations. In this study, we
examined how the addition of the small molecule oxa-
zine750 induced the formation of a parallel human telo-
meric G-quadruplex and regulated its conformational switch
in solution. To our knowledge, our results provide the first
insight into the selectivity and discrimination of oxazine750
for the human telomere sequence: not only can the ligand
preferentially induce a parallel formation from a random
coil telomeric oligonucleotide in the absence of added
cations, it also can easily surpass the energy barrier between
two structures and change the G-quadruplex conformation
in Naþ or Kþ solution. Of importance, the combination of
its unique properties, including the size and shape of the
G-quadruplex and the small molecule, is proposed as the
predominant force for regulating the special structural
formation and transitions. Crowding and crystal packing
force can influence the type of G-quadruplex conformation,
and it is also likely that small ligands can have equivalent
effects on the identity of the conformations found. Given
the apparent prevalence of DNA quadruplexes in biology
and their applications in nanoscience, ligands such as
oxazine750 present the possibility of being able to control
biological phenomena, functional molecules, and nanomate-
rials. For example, if a G-quadruplex-forming sequence or
a G-qudruplex is naturally present in genomic DNA,
inducing a quadruplex or changing a quadruplex conforma-
tion on a specific ligand binding could subsequently change
its molecular recognition, such as by disrupting the existing
protein interaction and introducing new protein recognition.
Furthermore, the specific interaction of oxazine750 with the
human telomere sequence as described in this study can be
used to gain an understanding of the biological roles
played by quadruplexes, and to design next-generation
molecules. Small ligands with more selectivity and discrim-
ination for the sequence could be obtained through modifi-
cation. Finally, our results indicate that a specific ligand-
G-quadruplex interaction is essential for the structural
transition and may be stronger than the Naþ/or Kþ coordi-
nation to the guanine O6, and it should be taken into account
when the cellular responses to these agents are being
evaluated.Biophysical Journal 97(7) 2014–2023
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